Dapoxetine Hydrochloride Powder CAS 129938-20-1 Raw Materials

CAS:119356-77-3

MF: C21H24ClNO

MW: 341.88

EINECS: 640-411-8

Specification​: 99% min Dapoxetine Hydrochloride

Sample: Dapoxetine Hydrochloride Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Dapoxetine Hydrochloride Powder Usage and Synthesis.

Dapoxetine Hydrochloride Powder is chemically known as (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-phenylpropylamine hydrochloride.

Dapoxetine Hydrochloride CAS 129938-20-1 has similar pharmacological effects to other SSRIs and initially Dapoxetine Hydrochloride Raw Materials was originally studied as an antidepressant, but unlike other SSRIs, the pharmacokinetics of Dapoxetine Hydrochloride Raw Materials showed rapid oral absorption, short half-life and rapid excretion, 

making Dapoxetine Hydrochloride Powder is suitable for on-demand administration for the treatment of premature ejaculation.

Uses and functions of Dapoxetine Hydrochloride Powder.

Dapoxetine hydrochloride is a white to off-white powder; it is soluble in methanol and ethanol, slightly soluble in ethylene dichloride and practically insoluble in water. Dapoxetine hydrochloride is a BCSII compound and poor solubility is a key factor in the difference in clinical efficacy. There are several crystalline forms of dapoxetine hydrochloride and the solubility of different crystalline forms varies considerably and there is phase to phase conversion between the crystalline forms.

Dapoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor (SSRI).

Dapoxetine impurities are organic synthesis intermediates and pharmaceutical intermediates that can be used in laboratory research and development processes and in chemical and pharmaceutical synthesis, mainly as intermediates for the API dapoxetine HCl.

Dapoxetine HCl (LY-210448) is a short-acting, novel selective 5-hydroxytryptamine reuptake inhibitor.

It is used to treat men aged 18 to 64 years with premature ejaculation (PE) who meet all of the following criteria:

• 1. Persistent or recurrent ejaculation occurs before, during or shortly after vaginal penetration and before sexual satisfaction due to minimal sexual stimulation.
• 2. Significant personal distress or interpersonal difficulties due to premature ejaculation (PE).
• 3. Poor ejaculatory control.

Pharmacological Effects of Dapoxetine Hydrochloride Powder.

Dapoxetine Hydrochloride, the name of the western drug. Commonly used in the form of tablets. It is used for erectile dysfunction. For the treatment of premature ejaculation (PE) in men between the ages of 18 and 64 years in whom all of the following conditions are met: persistent or repeated ejaculation before, during or shortly after vaginal insertion and before sexual satisfaction due to minimal sexual stimulation alone;

Significant personal distress or interpersonal difficulties due to premature ejaculation (PE); poor ejaculatory control.

The mechanism of action of dapoxetine in the treatment of premature ejaculation may be related to its inhibition of neuronal reuptake of 5-hydroxytryptamine, thereby affecting the potential difference between the neurotransmitter's action on the cell's pre- and postsynaptic receptors.

In humans, ejaculation is mainly mediated by the sympathetic nervous system. The reflex pathway for ejaculation originates from the spinal reflex centre, which is mediated by the brainstem and which is initially influenced by a number of brain nuclei (medial preoptic nucleus and inferior paraventricular nucleus).

In rats, dapoxetine inhibits the ejaculatory drive reflex by acting at the supraspinal level, where the lateral paracellular giant nucleus (LPGi) is an essential brain structure. The postganglionic sympathetic fibres that innervate the seminal vesicles, vas deferens, prostate, urethral bulb muscles and bladder neck allow these organs to contract in concert to achieve ejaculation.

Dapoxetine modulates this ejaculatory reflex in rats, thereby prolonging the latency of the pubic motor neuron reflex discharge (PMRD) and reducing the duration of the PMRD.